4.4 Article

Efficacy and safety of sitagliptin and the fixed-dose combination of sitagliptin and metformin vs. pioglitazone in drug-naive patients with type 2 diabetes

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biochemistry & Molecular Biology

Thiazolidinediones and the liver in humans

Hannele Yki-Jarvinen

CURRENT OPINION IN LIPIDOLOGY (2009)

Review Endocrinology & Metabolism

Standards of Medical Care in Diabetes-2009

DIABETES CARE (2009)

Article Medicine, General & Internal

Efficacy and safety of sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes

Itamar Raz et al.

CURRENT MEDICAL RESEARCH AND OPINION (2008)

Editorial Material Medicine, General & Internal

Rosiglitazone no longer recommended

[Anonymous]

LANCET (2008)

Article Endocrinology & Metabolism

Efficacy and safety of sitagliptin when added to ongoing metformin therapy in patients with type 2 diabetes

R. Scott et al.

DIABETES OBESITY & METABOLISM (2008)

Review Pharmacology & Pharmacy

Inhibitors of dipeptidyl peptidase IV:: a novel approach for the prevention and treatment of Type 2 diabetes?

CF Deacon et al.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2004)

Review Pharmacology & Pharmacy

Glucagon-like peptide 1 and inhibitors of dipeptidyl peptidase IV in the treatment of type 2 diabetes mellitus

JJ Holst et al.

CURRENT OPINION IN PHARMACOLOGY (2004)

Review Pharmacology & Pharmacy

Metformin - New understandings, new uses

RS Hundal et al.

Article Medicine, General & Internal

A diabetes report card for the United States: Quality of care in the 1990s

JB Saaddine et al.

ANNALS OF INTERNAL MEDICINE (2002)